Investigators in the Division of Pulmonary, Allergy and Critical Care Medicine have made a monumental discovery regarding idiopathic pulmonary Thannickalfibrosis, an often fatal lung disease with no cure and no effective treatments. In findings published March 1, 2013, in the Journal of Clinical Investigation, the research team has discovered a new pathway that contributes to fibrosis, or scarring in the lungs. More importantly, they may have also found a potential treatment to block that pathway.

To read more, go to: http://www.uab.edu/news/latest/item/3282-uab-researchers-discover-possible-treatment-for-incurable-lung-disease

 

Department Chair Seth Landefeld, MD, Appointed to U.S. Preventive Services Task Force
Good News Update
Week of April 18, 2016
State of the Department 2015
Our Shared Successes as Told by 27 Faculty and Trainees

Medical Grand Rounds Calendar

Research Spotlight April 2016
EOM Freiger
Ask the Chair of the Department of Medicine